Hysteroscopic Myomectomy
ProcedureHysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).
Not Yet Recruiting
NCT Number: NCT07578246
"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.
Not Yet Recruiting
Trial opening soon.
Get NotifiedKey information
Conditions
Age range
18 year–45 year
Sex eligibility
Female
Study type
Observational
About this study
This study aims to evaluate the applicability of LASMAR scoring in predicting surgical outcomes for cases of hysteroscopic myomectomy. By applying the LASMAR scoring system to patient , the study seeks to determine if the scoring can accurately predict operative time, completeness of resection, and complication rates.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Women aged 18-45 years
- Type 0,1,2 Fibroids according to Figo classification.
- Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.
- Fibroids size ≤ 5 cm in diameter
- Confirmed diagnosis of leiomyoma by ultrasound .
- Hemodynamically Stable Patients: Patients with no significant anemia.
Exclusion criteria
- Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)
- Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).
- Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).
- Fibroid Size>5 cm.
Treatment and study plan
Primary outcomes
-
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications.
Time frame: 2 years
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications
Secondary outcomes
-
Postoperative Complications: Including infection, adhesions, volume overload.
Time frame: 2 years
Postoperative Complications: Including infection, adhesions, volume overload.
-
Need for Further Interventions: Incidence of additional treatments like hormonal therapy
Time frame: 2 years
Need for Further Interventions: Incidence of additional treatments like hormonal therapy
Study contacts
Contact information is provided by the study sponsor or research team.
Ahmed Mohammed Selim, MD
CONTACT
Yomna Ayman Salah, Master degree
CONTACT
Sponsors and collaborators
Lead sponsor
Ain Shams University
Other
Registry information
Official study title
Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
Important dates
- Study start
- 2026
- Primary completion
- 2028
- Study completion
- 2028
- First posted
- May 11, 2026
- Registry last updated
- May 11, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.